Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 4/20 | 0.59 |
| ▸ | BACE1 | P56817 | 2/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.59 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.58 |
| ▸ | TRPM7 | Q96QT4 | 1/20 | 0.58 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.58 |
| ▸ | MAOB | P27338 | 4/20 | 0.58 |
| ▸ | PTGES | O14684 | 2/20 | 0.52 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.52 |
| ▸ | CNR2 | P34972 | 1/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.51 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.51 |
| ▸ | PPARG | P37231 | 2/20 | 0.48 |
| ▸ | PPARD | Q03181 | 1/20 | 0.48 |
| ▸ | PPARA | Q07869 | 1/20 | 0.48 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.48 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.48 |
| ▸ | DHODH | Q02127 | 1/20 | 0.47 |
| ▸ | CTSL | P07711 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4126421 | 0.83 | MAOB (0.64) | APPBACE1PTPN1SLC6A3TRPM7 | |
| SCHEMBL4126419 | 0.83 | MAOB (0.64) | APPBACE1PTPN1SLC6A3TRPM7 | |
| SCHEMBL15364121 | 0.80 | DHODH (0.69) | APPBACE1PTPN1SLC6A3TRPM7 | |
| SCHEMBL15364116 | 0.80 | DHODH (0.69) | APPBACE1PTPN1SLC6A3TRPM7 | |
| SCHEMBL29572464 | 0.79 | DHODH (0.71) | APPBACE1PTPN1SLC6A3TRPM7 | |
| SCHEMBL13214111 | 0.79 | SLC6A3 (0.85) | APPBACE1PTPN1SLC6A3TRPM7 | |
| SCHEMBL29530411 | 0.79 | SLC6A3 (0.85) | APPBACE1PTPN1SLC6A3TRPM7 | |
| SCHEMBL19714693 | 0.79 | SLC6A3 (0.85) | APPBACE1PTPN1SLC6A3TRPM7 | |
| SCHEMBL22106052 | 0.75 | SLC6A3 (0.82) | APPBACE1PTPN1SLC6A3TRPM7 | |
| SCHEMBL29217331 | 0.75 | SLC6A3 (0.90) | APPBACE1PTPN1SLC6A3TRPM7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017175064-A1 | BIOENZYMATIC SYNTHESIS OF TETRAHYDROCANNABIVARIN (THC-V), CANNABINOL (CBN), AND CANNABIVARIN (CBV) AND THEIR USE AS THERAPEUTIC AGENTS | FULL SPECTRUM LABORATORIES LTD (IE) | 2017-10-12 | — | — | WO | disclosed |
| US-20170283837-A1 | BIOENZYMATIC SYNTHESIS OF THC-v, CBV AND CBN AND THEIR USE AS THERAPEUTIC AGENTS | TUATARA CAPITAL FUND I, L.P. | 2017-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170283837-A1 | BIOENZYMATIC SYNTHESIS OF THC-v, CBV AND CBN AND THEIR USE AS THERAPEUTIC AGENTS | CNR1, CNR2, BCHE | APP 2315/4885BACE1 147/4885PTPN1 4532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.